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Abstract
Aim/hypothesis. By acting in the brain, insulin sup-
presses food intake. However, little is known with re-
gard to insulin signalling in the hypothalamus in insu-
lin-resistant states.
Methods. Western blotting, immunohistochemistry
and polymerase chain reaction assays were combined
to compare in vivo hypothalamic insulin signalling
through the PI3-kinase and MAP kinase pathways be-
tween lean and obese Zucker rats.
Results. Intracerebroventricular insulin infusion re-
duced food intake in lean rats to a greater extent than
that observed in obese rats, and pre-treatment with
PI3-kinase inhibitors prevented insulin-induced an-
orexia. The relative abundance of IRS-2 was consider-
ably higher than that of IRS-1 in hypothalamus of
both lean and obese rats. Insulin-stimulated phosphor-
ylation of IR, IRS-1/2, the associations of PI 3-kinase
to IRS-1/2 and phosphorylation of Akt in hypothala-
mus were decreased in obese rats compared to lean
rats. These effects seem to be mediated by increased
phosphoserine content of IR, IRS-1/2 and decreased
protein levels of IRS-1/2 in obese rats. In contrast, in-
sulin stimulated the phosphorylation of MAP kinase
equally in lean and obese rats.
Conclusion/interpretation. This study provides direct
measurements of insulin signalling in hypothalamus,
and documents selective resistance to insulin signal-
ling in hypothalamus of Zucker rats. These findings
provide support for the hypothesis that insulin could
have anti-obesity actions mediated by the PI3-kinase
pathway, and that impaired insulin signalling in hypo-
thalamus could play a role in the development of 
obesity in this animal model of insulin-resistance.
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Insulin receptors (IR) are expressed in most tissues of
the body, including the classic insulin-sensitive tissues
(liver, muscle and fat), as well as “insulin-insensitive”
tissues, such as red blood cells and neurons of the
CNS. In the CNS, the IR has distinct patterns of ex-
pression in the olfactory bulb, the hypothalamus and
the pituitary [1, 2, 3], although its function in these re-
gions is not completely understood. Previous studies
have documented a role for insulin signalling in the
regulation of food intake [4, 5, 6, 7, 8].
In the past decade, many of the proteins involved in
insulin action have been defined at the molecular level
in non-hypothalamic cells. The insulin receptor is a
protein tyrosine kinase which, when activated by insu-
lin binding, undergoes rapid autophosphorylation and
phosphorylates intracellular protein substrates, includ-
ing insulin receptor substrates (IRSs—IRS-1 and IRS-
2 are the most important) [9, 10, 11] and Shc [12].
Following tyrosine phosphorylation, the IRSs act as
docking proteins for several Src homology 2 domain-
containing proteins, including phosphatidylinositol 3-
kinase (PI3-kinase), Grb2, SHP2, Nck and Fyn [13,
14, 15, 16, 17]. Downstream to PI 3-kinase there is 
activation of a serine/threonine kinase, Akt [18]. In
contrast, downstream to Grb2 there is activation of 
the mitogen-activated protein kinase (MAPK-ERK),
which is important in the regulation of gene-expres-
sion and cell growth [19, 20, 21].
Besides its epidemiological association with obesi-
ty, insulin resistance and hyperinsulinaemia could also
primarily contribute to the development of obesity
[22]. Mechanisms to explain the weight gain caused
by insulin resistance and hyperinsulinaemia have been
attributed to defective insulin signalling in the hypo-
thalamus [4, 6, 22, 23, 24, 25, 26]. However, the intra-
cellular mechanisms involved are largely unknown. In
light of recent studies showing that the hypothalamic
PI3-kinase pathway is central for the control of food
intake [27, 28], we decided to characterize the direct
actions of insulin on the PI3-kinase and MAPK path-
ways in the hypothalamus of both lean and obese
Zucker rats.
Materials and methods
Animals. We studied 4- to 5-month-old male Zucker rats
(Charles River Breeding Laboratories, Wilmington, Mass.,
USA). All experiments involving animals were in accordance
with the guidelines of the Brazilian College for Animal Exper-
imentation (COBEA) and were approved by the ethics com-
mittee at the University of Campinas. Room temperature was
maintained between 21–23°C, rats were housed in individual
cages, subjected to a standard light-dark cycle (06:00–18:00/
18:00–06:00) and provided with standard rodent chow and wa-
ter ad libitum. All experiments for determination of food con-
sumption and insulin signalling were started between 17:00
and 18:00.
Reagents. Insulin (Eli Lilly, Indianapolis, Ind.,USA) was
stored at 4°C. Stock solutions were diluted in saline immedi-
ately before each experiment. The PI3-kinase inhibitors,
Wortmannin and LY294002 (Calbiochem, San Diego, Calif.,
USA), were dissolved in dimethyl sulfoxide and further diluted
in saline (dimethyl sulfoxide 0.1%).
Determination of plasma glucose and serum insulin concentra-
tion. Plasma glucose was measured by glucose oxidase method
in samples collected from the tail. Serum insulin was detected
by RIA, utilizing a guinea pig anti-rat insulin antibody and rat
insulin as standard [29].
Surgical procedures. After an overnight fast, the rats were ana-
esthetised with ketamine hydrochloride (100 mg/kg, ip) and
positioned on a Stoelting stereotaxic apparatus. The scalp was
removed in the midline to expose the saggital suture, and the
periosteum was then opened and reflected away from the sur-
gical field. The lateral, anteroposterior and dorsoventral coor-
dinates of the lateral ventricle were obtained from a standard
atlas [30]. The bregma was used as the reference point and a
hole was drilled in the parietal bone at the junction of the later-
al and anteroposterior coordinates. The cannula was positioned
over the hole and lowered carefully until the necessary dorso-
ventral coordinate was reached. The rats were then allowed to
recover from anaesthesia and the surgical procedure for 7 days.
Cannula placement was confirmed by a positive drinking re-
sponse after administration of angiotensin II (40 ng/2 µl), and
animals that did not drink 5 ml of water within 15 min after
treatment were not included in the experiment.
Treatments and measurement of food intake. Rats deprived of
food for 6 h with free access to water were i.c.v. injected (2 µl
bolus injection) with either vehicle, insulin (2 and 200 mU),
Wortmannin (100 nmol/l), or LY294002 (50 µmol/l). Thereaf-
ter standard chow was given and food intake was determined
by measuring the difference between the weight of chow given
and the weight of chow at the end of a 12-h period. Similar
studies were carried out in rats that were initially i.c.v. injected
with the PI3-kinase inhibitors, Wortmannin (100 nmol/l) or
LY294002 (50 µmol/l), or vehicle, and after 30 min with insu-
lin (200 mU). In preliminary experiments we determined plas-
ma glucose and serum insulin concentrations in animals that
received i.c.v. insulin infusion. Insulinaemia and plasma glu-
cose were not altered by lateral ventricle insulin or saline mi-
croinjection (data not shown).
Polymerase chain reaction (PCR) amplification and digestion
of PCR products. PCR amplification was carried out on isolat-
ed DNA from blood of lean and obese rats using a GFXTM ge-
nomic blood DNA purification kit (Amersham Pharmacia Bio-
tech, Piscataway, N.J., USA) according to the manufacturer’s
instructions. Primers, (5′-GTT TGC GTA TGG AAG TCA
CAG-3′) and (5′-ACC AGC AGA GAT GTA TCC GAG-3′)
were used to amplify products from 100 ng genomic DNA.
PCR reactions were carried out in 50 µl containing 100 ng
DNA, 100 ng of each primer, 500 µmol/l dNTPs, 1× Buffer 3
from the expanded long template PCR kit (Boehringer Mann-
heim Biochemicals, Indianapolis, Ind., USA), 0.25 µl each of
AmpliTaq Polymerase (Perkin Elmer, Boston, Mass., USA)
and Taq extender (Stratagene, La Jolla, Calif., USA). The am-
plification protocol was 32 cycles at 92°C for 30 s, at 54°C for
1 min and at 68°C for 5 min. All PCR products were digested
with MspI overnight at 37°C and analyzed on a 1% agarose
gel.
Western blot analysis. The rats were anaesthetised with sodium
amobarbital (15 mg/kg body weight, ip), and used as soon as
anaesthesia was assured by the loss of pedal and corneal re-
flexes. Rats were i.c.v. injected (2 µl bolus injection) with 
either vehicle, insulin (2 and 200 mU), or Wortmannin
(100 nmol/l), LY294002 (50 µmol/l). After the appropriate
time interval (15 min), the rats were killed, the cranium was
opened and the basal diencephalon, including the pre-optic 
area and the hypothalamus, was quickly removed, minced
coarsely and homogenized immediately in the solubilization
buffer containing 100 mmol/l Tris (pH 7.6), 1% Triton X-100,
150 mmol/l NaCl, 0.1 mg aprotinin, 35 mg PMSF/ml,
10 mmol/l Na3VO4, 100 mmol/l NaF, 10 mmol/l Na4P2O7, and
4 mmol/l EDTA, using a Polytron PTA 20S generator operated
at maximum speed for 30 s and clarified by centrifugation. In-
variably two hypothalami were pooled and 200 µg of protein
were used as whole tissue extract for Akt and Erk analysis or
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1 mg protein for immunoprecipitation followed by western
blot for IR and IRS-1/2 with the indicated antibodies and
[125I]Protein A. Quantitative analysis of the blots was done us-
ing Scion Image software (Scion Corporation, Frederick, Md.,
USA). [125I]Protein A bound to the anti-phosphotyrosine and
antipeptide antibodies was detected by autoradiography using
preflashed Kodak XAR film (Eastman Kodak, Rochester, N.Y.,
USA) with Cronex Lightning Plus intensifying screens at 
−80°C for 12–48 h. Similar studies were done in rats i.c.v. in-
jected with the PI3-kinase inhibitors, Wortmannin (100 nmol/l)
or LY294002 (50 µmol/l), and 30 min after with insulin
(200 mU). The antibodies against IR (sc-711), IRS-1 (sc-559),
IRS-2 (sc-8299), ERK (sc-93), p-ERK (sc-7383), Shc (sc-288),
Akt1 (sc-1618) and anti-phosphotyrosine (sc-508) were ob-
tained from Santa Cruz Biotechnology (Santa Cruz, Calif.,
USA). Antibodies against the p85 subunit of PI3-kinase
(06–195) were from Upstate Biotechnology (Lake Placid,
N.Y., USA). Antibodies against Akt phosphoserine specific
(9271L) were purchased from Cell Signaling Technology
(Beverly, Mass., USA). Phospho-Serine antibodies (AB1603)
were obtained from Chemicon International (Temecula, Calif.,
USA).
Since different antibody affinities towards IRS-1 and IRS-2
could raise concerns about hypothalamic substrate concentra-
tion and its tyrosine phosphorylation we evaluated the affinity
of the antibodies used in this study (IRS-1 sc-559; IRS-2 
sc-8299). For this purpose a protein A Sepharose column was
assembled and the affinity of each antibody to liver IRS-1 and
IRS-2 was tested under a salt gradient [31, 32]. The affinity of
sc-559 towards IRS1 was about three-fold higher than the af-
finity of sc-8299 towards IRS-2. Antibody cross-reactivity was
almost undetectable as evaluated by eluate separation on SDS-
PAGE and western blot analysis.
Immunohistochemistry. Rat hypothalami were fixed in 4% para-
formaldehyde/0.2 mol/l phosphate-buffered saline (pH 7.4) for
24 h, embedded in paraffin, and 5 µm sections were obtained.
The glass-mounted sections were cleared from paraffin with
xylene and re-hydrated by sequential washings with graded
ethanol solutions (70–100%). After permeabilization with
0.1% Triton X-100 in phosphate-buffered saline, pH 7.4, for
10 min at room temperature, the sections were incubated in 1%
H2O2 in phosphate-buffered saline for 30 min to quench the
endogenous peroxidase activity. The sections were pre-treated
in a microwave oven in sodium citrate buffer (pH 7.4) for
10 min. After being washed in phosphate-buffered saline, the
sections were blocked by 3% non-fat dry milk in phosphate-
buffered saline for 1 h at 37°C, followed by overnight incuba-
tion with the primary antibody (rabbit anti-IR, rabbit anti-IRS1
or goat anti-IRS2) in 1% BSA in phosphate-buffered saline at
4°C in a moisture chamber. After incubation with the primary
antibody, sections were washed and incubated with a specific
biotinylated anti-rabbit secondary antibody (1:150 dilution) for
2 h at room temperature, followed by incubation with Strepto-
avidin reagent (containing avidin-conjugated peroxidase) and
colour reaction using the DAB substrate kit (Vector Laborato-
ries, Burlingame, Calif., USA) according to recommendations
of the manufacturer. After the colour reaction, sections were
counterstained with Harris haematoxylin, dehydrated through
an ethanol series into xylene and mounted using Entellan
mounting media (Microscopy, Darmstadt, Germany). Second-
ary antibody specificity was tested in a series of positive and
negative control measurements. In the absence of primary anti-
bodies, application of secondary antibodies (negative controls)
failed to produce any staining. The images were obtained using
an optical microscope (Leica, Wetzlar, Germany) and a Focus
Imagecorder Plus System. For double immunofluorescence
staining FITC and rhodamine conjugated secondary antibodies
were used and analysis and photo-documentation were done
using a Zeiss LSM 510 Laser Scanning Confocal Microscope
[33].
Statistical analysis. Where appropriate, the results were ex-
pressed as the means ± SEM accompanied by the indicated
number of rats used in experiments. Comparisons among
groups were made using parametric two-way ANOVA, where
F ratios were significant. Further comparisons were made us-
ing Newman-Keuls test. A p value of less than 0.05 was con-
sidered statitically significant.
Results
Intracerebroventricular insulin reduces food intake in
lean rats to a greater extend than in obese Zucker
rats. The obese rats were heavier and had higher plas-
ma glucose and fasting serum insulin concentrations
than their age-matched lean controls (Table 1). The ef-
fect of insulin (2 and 200 mU) or its saline vehicle on
the control of food intake was studied in 6-h fasted
rats by measuring the total food intake for 12-h after a
single i.c.v. injection of insulin or its saline vehicle
just before the onset of the dark cycle. Insulin, in a
concentration-dependent manner, induced reductions
in the 12-h food intake of both lean (+/?) and obese
(fa/fa) rats. In the lean rats, insulin (2 mU and
200 mU) food intake by about 50% and about 90%,
respectively, while in the obese rats these doses in-
duced reductions of about 30% and about 45% respec-
tively, indicating that insulin was much less effective
in obese rats (Fig. 1).
Detection of the A880 to C mutation in genomic DNA.
In order to genotype lean and obese animals PCR
primers that amplify a 157-bp cDNA fragment, con-
taining the A880 to C mutation, were used to amplify
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Table 1. Characteristics of obese Zucker (fa/fa) rats and their age-matched lean Zucker (Fa/?) controls
Groups Number of rats Body weight Plasma glucose Fasting insulin Post-prandial insulin 
(n) (g) (mmol/l) (pmol/l) (pmol/l)
Lean (+/+) 6 254±27 4.6±0.28 104.2±27.8 771.8±56.1
Lean (+/fa) 6 265±21 4.88±0.33 131.9±55.6 817.8±74.3
Obese (fa/fa) 10 394±20* 6.16±0.22* 1757.1±111.1* 7028.6±390.9*
* p<0.001 vs. lean group
genomic DNA. A 1.8-kb product was generated. MspI
digestion of the 1.8-kb fragment from homozygous
lean animals showed a single restriction site (Fig. 2a,
lane 1). In contrast, MspI digestion of genomic prod-
ucts from fa/fa rats resulted in an additional cleavage
of the largest fragment (lane 3). Some products from
lean rats generated an MspI digestion pattern indicat-
ing that these lean animals were heterozygous for the
mutation (lane 2).
In vivo effect of insulin on tyrosine phosphorylation of
IR in the hypothalamus. The protein expression of IR
in the hypothalamus from lean +/+, lean +/fa and
obese rats was quantitated by immunoprecipitation
and immunoblotting with αIR antibodies. The IR pro-
tein levels were not different between lean +/+, lean
+/fa and obese rats (Fig. 2b).
The effect of in vivo i.c.v. insulin infusion on IR ty-
rosine phosphorylation was examined in the hypothal-
amus of Zucker lean (+/?) and obese (fa/fa) rats. Hy-
pothalami from insulin or vehicle-treated rats were
submitted to immunoprecipitation with anti-IR anti-
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Fig. 1. Dose-related inhibition of the 12-h cumulative food in-
take induced by insulin in lean (L) and obese (F) Zucker rats
fasted for 6 h. Vehicle or insulin was injected i.c.v. at the onset
of the dark cycle and rats were immediately exposed to food
for 12 h. Data are expressed as means ± SEM of 8–14 animals
per group. # p<0.05, ## p<0.001, vs the respective lean insulin-
treated group. *p<0.05, **p<0.001, vs. vehicle injected rats
Fig. 2a–d. Detection of A880 to C mutation in genomic DNA,
IR protein expression and tyrosine or serine phosphorylation in
the hypothalamus of lean (L) and obese (F) Zucker rats in vi-
vo. (a) Blood DNA amplification and MspI digestion of PCR
products from lean and fa/fa rats. Lane 1: Wild-type lean rat
(+/+), Lane 2: Heterozygous lean rat (+/fa), Lane 3: Obese
fa/fa rat. (b) IR protein levels. Isolated hypothalami were ho-
mogenized, and equal amounts of protein were subjected to
immunoprecipitation (IP) with αIR, separated by SDS-PAGE,
and immunoblotted (IB, immunoblotting) with the same anti-
body. (c) Insulin-induced IR tyrosine phosphorylation. Hypo-
thalamic extracts from lean and obese rats treated with insulin
or vehicle for 15 min. Tissue extracts were immunoprecipitat-
ed with anti-IR antibody and immunoblotted with anti-pho-
sphotyrosine antibody (pY). (d) IR serine phosphorylation.
Isolated hypothalami were homogenized, and equal amounts of
protein were subjected to immunoprecipitation with αIR, sepa-
rated by SDS-PAGE, and immunoblotted (with anti-phospho-
serine antibody (pSer). Data (means ± SEM; n=8–10) are ex-
pressed as relative to control, assigning a value of 100% to the
lean insulin mean. *p<0.05 vs the respective lean insulin-treat-
ed group
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body and then blotted with anti-phosphotyrosine anti-
body. Insulin, in a concentration-dependent manner,
induced increases in IR tyrosine phosphorylation lev-
els in hypothalamus from both lean and obese rats. In
the lean animals, insulin (2 mU and 200 mU) in-
creased IR tyrosine phosphorylation by 4.9- and 9.1-
fold, respectively, compared with 2.8- and 3.9-fold in-
creases in the hypothalami from obese rats, represent-
ing reductions in IR tyrosine phosphorylation of 53%
and 65% respectively (Fig. 2c). To determine whether
the decreases in IR tyrosine phosphorylation in the
obese rats were associated with an increase in IR ser-
ine phosphorylation, we carried out immunoprecipita-
tion with anti-IR antibody and then blotted with anti-
phosphoserine antibody. The basal levels of IR serine
phosphorylation were 4.5-fold higher in obese than in
lean rats (Fig. 2d).
The fa/+ rats had similar weight as the +/+ animals,
with mean body weight of 254.5±27.5 and 265.0±
21.2, respectively. To assess if the Zucker mutation in
the leptin receptor interferes with the control of food
intake we measured the food intake of 6-h fasted lean
fa/+ and +/+ rats for 12 h after a single injection of in-
sulin.The i.c.v. injection of insulin induced similar re-
ductions in food intake of both lean fa/+ and lean +/+
rat (data not shown). Insulin-stimulated tyrosine phos-
phorylation of IR equally in hypothalamus of both
lean +/+ and lean +/fa rats (Fig. 2c).
Effect of insulin on tyrosine phosphorylation of IRS-
1/2 and their association with the p85 subunit of PI 3-
kinase in the hypothalamus. Insulin, in a concentra-
tion-dependent manner, induced increases in IRS-1
and IRS-2 tyrosine phosphorylation levels in hypo-
thalamus from both lean and obese rats. In the lean
animals, insulin (2 mU and 200 mU) increased IRS-1
tyrosine phosphorylation by 5.0- and 7.9-fold, respec-
tively, compared with 2.5- and 4.2-fold increases in
the hypothalami from obese rats, representing reduc-
tions of 62% and 54% in IRS-1 tyrosine phosphoryla-
tion, respectively (Fig. 3a). Insulin (2 mU and
200 mU) stimulated increases of 6.3-fold and 8.5-fold
in IRS-2 tyrosine phosphorylation, respectively, in the
hypothalamus of lean rats (Fig. 3b, upper panel),
compared with increases of 3.3- and 3.5-fold, respec-
tively, in the hypothalamus of obese rats, representing
Fig. 3a–d. IRS-1 and IRS-2 protein expression, tyrosine and
serine phosphorylation, and their association with the p85 sub-
unit of PI 3-kinase in the hypothalamus of lean (L) and obese
(F) Zucker rats in vivo. (a, b—upper panel) Insulin-stimulated
tyrosine phosphorylation of IRS-1 and IRS-2. Hypothalami
from rats treated with insulin or vehicle for 15 min were lysed,
and tissue extracts were immunoprecipitated with anti-IRS-1
or anti-IRS-2 antibodies and blotted with anti-phosphotyrosine
antibody (pY). (a, b—bottom panel) The same membranes
used for IRS-1 and IRS-2 tyrosine phosphorylation were
stripped and re-blotted with anti-PI3-kinase antibodies. Isolat-
ed hypothalami were homogenized, and equal amounts of pro-
tein were subjected to immunoprecipitation (IP) with αIRS-1
or αIRS-2, separated by SDS-PAGE, and immunoblotted (IB,
immunoblotting) with the same antibody (c) or with anti-pho-
sphoserine antibody (pSer) (d). The bar graph shows the quan-
titative serine phosphorylation of IRS-1 and IRS-2. Data
(means ± SEM; n=8) are expressed as relative to control, as-
signing a value of 100% to the lean insulin mean. *p<0.05,
lean vs obese
decreases of 43% and 66% in the obese rats (p<0.05).
The same membranes used to detect tyrosine phos-
phorylation of IRS-1 and IRS-2 were reblotted with
antibodies against the p85 subunit of PI3-kinase. The
PI3-kinase association to IRS-1 and IRS-2 paralleled
the changes in phosphorylation of these proteins
(Fig. 3a,b—bottom panels). The protein expression of
IRS-1 and IRS-2 in the hypothalamus from control
and obese rats were quantitated by immunoprecipita-
tion and immunoblotting with αIRS-1 or αIRS-2 anti-
bodies and decreases of 35% and 20%, respectively,
were detected in the hypothalamus of obese rats when
compared to the lean controls. Based on differential
affinity of IRS-1 and IRS-2 antibodies and on data de-
scribed above we conclude that the relative abundance
of IRS-1 is considerably lower than that of IRS-2 in
hypothalamus of lean rats. It is noteworthy that the
differences between IRS-1 and IRS-2 are preserved in
obese rats (Fig. 3c). The protein levels of PI3-kinase
were not different in the hypothalamus of lean and
obese animals. The basal levels of IRS-1 and IRS-2
serine phosphorylation were compared in IRS-1 and
IRS-2 immunoprecipitates from the hypothalamus of
both lean and obese rats. The basal levels of IRS-1
and IRS-2 serine phosphorylation were 4.4 and 3.2
times higher in obese rats than in the lean ones
(Fig. 3d).
Distribution of IR, IRS-1 and IRS-2 in hypothalamus
of obese and lean Zucker rats. In the face of an appar-
ent molecular impairment in insulin signal transduc-
tion in the hypothalamus of obese Zucker rats, we de-
cided to test if there would be any difference in the
expression and histological distribution of IR, IRS-1
and IRS-2 between hypothalami of obese and lean
Zucker rats. In an initial series of experiments, hypo-
thalami of three obese and three lean Zucker rats were
paraformaldehyde fixed and utilized in peroxidase
staining with IR, IRS-1 and IRS-2 primary antibodies.
Most IR immunoreactivity was detected in arcuate nu-
cleus (Arc), with only scattered neurons containing IR
appearing in periventricular nucleus (PVN) and poste-
rior hypothalamus (PH) (Fig. 4a). The same pattern of
distribution was true for IRS-2. However, IRS-1 hypo-
thalamic distribution had a particular characteristic,
with positive IRS-1 staining in several neurons of PH
and only some few cells staining positive for IRS-1 in
Arc (Fig. 4a, inset Arc/IRS-1 intersection). There
were no differences in distribution of IR, IRS-1 and
IRS-2 between hypothalami of obese and lean rats. In
order to investigate co-expression of IR with both
IRS-1 and IRS-2 we carried out double-staining con-
focal microscopy (Fig. 4b). By this technique most
neurons expressing IR in Arc were shown to possess
IRS-2, while only some of them co-expressed IRS-1.
Moreover, in PVN some, but not all cells expressing
IR were also positive for IRS-2. No neurons co-ex-
pressing IR and IRS-1 were seen in PVN. Finally, at
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PH, a site of high expression of IRS-1, we could de-
tect neurons expressing only IRS-1 and no IR and
some few cells expressing both proteins (Fig. 4b, PH
merge that a neuron containing only IRS-1 stains
clearly in green).
Fig. 4a, b. Immunohistochemical evaluation of IR, IRS1 and
IRS2 distribution in hypothalamus of Zucker (fa/fa) rats. In
paraformaldehyde fixed rat (fa/fa) hypothalamic sections
(5 µm) stained with the peroxidase technique (a) anti-IR (first
vertical column); anti-IRS1 (second vertical column); anti-
IRS2 (third vertical column). (b) Laser confocal analysis of
hypothalamic sections of obese Zucker rats double-labelled
with anti-IR (red staining) and anti-IRS-1 or anti-IRS-2 (green
staining) antibodies. Arc, arcuate nucleus; PVN, perive nucle-
us; PH, posterior hypothalamic area; 3V, third ventricle
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Role of PI 3-kinase in anorectic response to insulin.
Pharmacological inhibitors of PI3-kinase activity,
such as Wortmannin, can block insulin activity in vit-
ro, suggesting that PI3-kinase-dependent signalling is
needed for certain intracellular responses to insulin.
We tested whether the inhibitory effects of insulin on
food intake depend on PI3-kinase by i.c.v. infusion of
PI 3-kinase inhibitors into lean rats. Treatment with
insulin reduced 12-h food intake in rats pre-treated
with vehicle, but we did not detect insulin-induced an-
orexia after pre-treatment with Wortmannin (Fig. 5a).
By using LY294002, instead of Wortmannin in a dif-
ferent group of rats, we confirmed that infusion of
PI3-kinase inhibitors into the lateral cerebral ventricle
prevents the reduction in food intake induced by i.c.v.
administration of insulin (Fig. 5b). Akt is a serine/
threonine kinase that is serine-phosphorylated and can
be activated by insulin through the PI3-kinase path-
way. In the hypothalamus from lean rats, insulin in-
duced a marked increase in serine phosphorylation of
Akt (Fig. 4b,c—lane 3). To confirm the biological ef-
ficacy of PI3-kinase blockage with Wortmannin and
LY294002 we determined the effect of insulin on the
activation of Akt in rats pretreated with Wortmannin
and LY294002. Wortmannin and LY294002 prevented
insulin-induced serine phosphorylation of Akt in the
hypothalamus of lean rats (Fig. 5c,d—lane 4).
Serine phosphorylation of Akt and tyrosine phosphor-
ylation of MAP kinase (ERK-1/2) in hypothalamic tis-
sue. In hypothalamus from lean rats, insulin (2 and
200 mU) increased serine phosphorylation of Akt by
5.8- and 8.7-fold, respectively. The basal levels of ser-
ine phosphorylation of Akt were higher in hypothala-
mus of obese rats compared to lean animals (p<0.05;
n=10), and insulin (2 and 200 mU) increased Akt ser-
ine phosphorylation by only 1.5- and 1.9-fold respec-
tively, in those animals. Compared to the lean rats
there were reductions of 51% and 55% in insulin-in-
duced Akt phosphorylation in hypothalamus of obese
rats (Fig. 6a). The protein levels of Akt were not dif-
Fig. 5a–d. Blockade of insulin-induced inhibition of food in-
take by PI 3-kinase inhibitors. (a, b) Lean rats fasted for 6 h
were injected i.c.v. with either vehicle (2 µl), Wortmannin
(100 nmol/l) or LY294002 (50 µmol/l) and 30 min later were
injected with vehicle (2 µl) or insulin (200 mU) and were im-
mediately exposed to food for 12 h. Data are expressed as
means ± SEM of 6–8 animals per group. *p<0.05 relative to
controls (c, d) Insulin-stimulated serine phosphorylation of
Akt in hypothalamus of lean Zucker rats in vivo. Pre-treatment
with either vehicle (2 µl), Wortmannin (100 nmol/l) or
LY294002 (50 µmol/l) was followed 30 min later by i.c.v. ad-
ministration of vehicle (2 µl) or insulin (200 mU) for 15 min,
then the hypothalamus was lysed and the proteins were sepa-
rated by SDS-PAGE on 12% gels and blotted with phosphoser-
ine-specific AKT antibodies (IB, immunoblotting). A repre-
sentative western blot of each group is shown. Data (means 
± SEM; n=8) are expressed as relative to control. *p<0.05, rel-
ative to controls
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ferent in the hypothalamus of lean and obese animals
(Fig. 6a bottom).
Using antibodies against tyrosine-phosphorylated
ERK-1/2, the levels of ERK-1/2 phosphorylation were
examined in hypothalamus after insulin stimulation.
Insulin stimulated tyrosine phosphorylation of ERK-
1/2 equally in the hypothalamus of lean and obese
rats. Insulin (2 and 200 mU) increased tyrosine phos-
phorylation of ERK-1/2 by 3.7- and 4.4-fold in the hy-
pothalamus of lean rats, respectively, and by 3.5- and
4.2-fold in the hypothalamus of obese rats (Fig. 6b).
The protein levels of Shc (data not shown) and ERK-
1/2 (Fig. 6b bottom) were not different in the hypo-
thalamus of lean and obese animals.
Discussion
In this study, we have characterized insulin signalling
in the hypothalamus of lean and obese Zucker rats.
Obese Zucker rats have insulin resistance, hyperinsul-
inaemia, hyperlipidaemia and glucose intolerance,
features similar to those presented in obesity-related
insulin resistance and Type 2 diabetes mellitus [34].
We show that treatment with insulin reduces food in-
take in lean rats pre-treated with vehicle, but we did
not detect insulin-induced anorexia after pre-treatment
with PI3-kinase inhibitors. In contrast, in accordance
with a previous report [24], our results show that cen-
tral insulin administration is less effective in reducing
food intake in the obese Zucker rats. In addition, our
data show an impairment of insulin activation of the
PI3-kinase-Akt pathway in these animals. However,
insulin-stimulated tyrosine phosphorylation of ERK-
1/2 MAP kinase is similar in both phenotypes. Defec-
tive and pathway selective insulin action in the brain
could thus contribute to the pathogenesis of obesity in
the fa/fa rats.
Several mechanisms might be enrolled in the
pathogenesis of insulin resistance in hypothalamus
of obese Zucker rats. By decreasing the ability of cir-
culating insulin to enter brain interstitial fluid, where
it can bind to neuronal insulin receptors, impaired in-
sulin transport across endothelial cells of the blood-
brain barrier is one potential mechanism. Several
studies have indicated that insulin uptake into the
brain is facilitated by insulin receptors expressed by
endothelial cells in the blood-brain barrier that func-
tion as insulin transporters [35, 36]. The relationship
between cerebrospinal fluid and plasma insulin con-
centrations is not linear but is saturable, consistent
with a receptor-mediated transport process. This
non-linear relationship has been observed in moder-
ate diet-induced obesity rats [37]. High-fat diet-in-
duced obesity is also associated with reduced brain
insulin transport in dogs [38], and genetically obese
Zucker rats have impaired brain insulin transport
[39], which can be ascribed to a decreased number of
brain capillary insulin receptors [35]. Here we show
that the sites of insulin-signalling impairment seem
to be at the IR and post-receptor levels in the hypo-
thalamus of obese Zucker rats. Insulin-induced IR ty-
rosine phosphorylation is lower in the hypothalamus
of obese compared to the lean rats. The reduction in
IR tyrosine phosphorylation in the hypothalamus is
similar to that observed in the liver and vascular
cells of obese Zucker rats [40].
Fig. 6a, b. Effects of insulin on serine phosphorylation of Akt
and tyrosine phosphorylation of MAP kinase (ERK-1/2) in hy-
pothalamus of lean (L) and obese (F) Zucker rats in vivo. 
(a, b) Insulin-stimulated serine phosphorylation of Akt in hy-
pothalamus of lean (L) and obese (F) Zucker rats in vivo. Rats
fasted for 6 h were injected i.c.v. with vehicle (2 µl) or insulin
(200 mU), the hypothalamus was then lysed and the proteins
were separated by SDS-PAGE on 12% gels and blotted with
phosphoserine-specific AKT antibodies and with phosphotyro-
sine-specific ERK antibodies (IB, immunoblotting). A repre-
sentative western blot of each group is shown. Data (means 
± SEM; n=10) are expressed as relative to control, assigning a
value of 100% to the lean insulin mean. # p<0.05, vehicle lean
vs. vehicle obese, *p<0.05, insulin lean vs. insulin obese. 
(a, b—bottom panel) Stripped membranes were reblotted with
anti Akt and anti-ERK antibodies
Severe insulin resistance is a well-known feature of
leptin receptor mutation in the Zucker rats [34]. Insu-
lin resistance and hyperinsulinaemia occur early dur-
ing the life of these animals, are out of proportion to
their adiposity at early stages, and exceed the insulin
resistance and hyperinsulinaemia promoted by hyper-
phagia and obesity. Leptin’s effect on insulin sensitivi-
ty involves the central actions of leptin to modify me-
tabolism, and its direct effects at the level of insulin
target tissues [22]. Substantial data support the notion
that leptin could have important effects through direct
actions on peripheral target cells, including beta cells,
liver, muscle, and fat. Some evidence suggests that in
tissues such as muscle and beta cells, leptin promotes
lipid oxidation and inhibits lipid synthesis, which
would improve insulin sensitivity [41, 42, 43]. In con-
trast to the reduced insulin effects in hypothalamus of
obese rats, insulin-induced reduction in food intake is
similar in lean +/+ and lean +/fa rats. These results
could suggest that intermediate amount of functional
leptin receptor might be sufficient to the positive
cross-talk between insulin and leptin. However, in the
absence of leptin’s action in obese Zucker rats, the in-
sulin signal transduction is compromised in hypothal-
amus despite the very high fasting and post-prandial
insulin concentrations observed in these animals. An-
other possibility not to be excluded is that the hypo-
thalamic insulin resistance in obese Zucker rats could
be a secondary effect of obesity. Thus, the investiga-
tion of insulin signalling in hypothalamus of animal
models of diet-induced obesity is important and de-
serves further exploration.
As observed in the liver [44], a moderate decrease
in IRS-1 and IRS-2 protein expression occurs in the
hypothalamus of the obese rats. In parallel, there is
also a decrease in IRS-1 and IRS-2 tyrosine phosphor-
ylation, reflecting the decrease in protein levels as
well as a decrease in the stoichiometry of phosphory-
lation. These reductions are accompanied by a de-
crease in insulin-induced IRS-1 and IRS-2 association
with PI3-kinase and Akt phosphorylation. However,
the basal level of Akt serine phosphorylation is higher
in the hypothalamus of obese animals, probably as a
consequence of the hyperinsulinaemia, but only a mild
increase occurs after acute insulin infusion.
There are probably a number of mechanisms that
lead to an impairment of the insulin-signalling path-
way in the hypothalamus of obese Zucker rats. Our
results show that increased serine phosphorylation of
IR, IRS-1 and IRS-2 could be one of these mecha-
nisms. Previous studies clearly showed that an in-
crease in IR and IRSs serine phosphorylation could
induce insulin resistance, pointing to this as an im-
portant mechanism in the control of insulin signalling
[45, 46, 47]. It has been reported that activation of
PKC induces serine phosphorylation of IR, which can
inhibit its tyrosine kinase activity, leading to a de-
crease in insulin-induced PI3-kinase activity [48, 49].
Activation of protein kinase C-α, -β, -ε, and -δ has
been reported in skeletal muscle of obese Zucker and
diabetic Goto-Kakizaki rats [50]. Tumor-necrosis fac-
tor-α (TNF-α) has been suggested as an important
mediator of insulin resistance in obese animals
through its overexpression from fat tissue [51]. TNF-
α has been shown to produce serine phosphorylation
of IRS-1, resulting in reduced insulin receptor kinase
activity and insulin resistance [46]. In rodents, anti-
TNF-α reagents improved insulin resistance [52]. The
reduction in IRS-1 and IRS-2 protein levels in hypo-
thalamus of obese rats could also contribute to hypo-
thalamic insulin resistance in these animals. These re-
ductions in IRSs protein expression might be second-
ary to increased degradation of these proteins, as a
consequence of increased serine phosphorylation lev-
els [53], and/or be under transcriptional control. In
this regard, it was recently postulated that the genes
encoding IRSs are under transcriptional control of
leptin-induced JAK-STAT signalling pathways, rein-
forcing the positive cross-talk between insulin and
leptin [54]. According to immunohistochemical stud-
ies, differences in sub-anatomical expression of IRS-
1 and IRS-2 within the hypothalamus do not occur
between lean and obese Zucker rats; indeed, the rela-
tive abundance of IRS-1 is considerably lower than
that of IRS-2 in both lean and obese animals. Alto-
gether, this data with the results of confocal micros-
copy showing that there is a more concordant pres-
ence of IR and IRS-2 but not IRS-1 in neurons of dif-
ferent areas of hypothalamus, makes it reasonable to
speculate that IRS-2 could have a more important
role than IRS-1 in the insulin-induced activation of
the PI 3-kinase-Akt pathway in rat hypothalamus.
These results are in accordance with the recent report
of increased food intake and fat storage in female
IRS-2 knockout mice [55], a feature not observed in
IRS-1 knockout mice [56].
Selective impairment of insulin signalling through
PI3-kinase pathway in the hypothalamus could be
pathophysiologically important in the development of
obesity. Recent studies have shown that activation of
the PI3-kinase pathway could be involved in the an-
orexigenic effect of insulin or leptin [27, 28]. Taken
together with our data in an insulin-resistant state,
these findings might indicate that the anti-obesity ac-
tions induced by insulin could be blunted due to the
partial inhibition of the PI3-kinase pathway suggest-
ing that neuronal PI3-kinase is important for the ef-
fects of insulin on food intake. If the mechanism used
by insulin to reduce food intake is PI3-kinase-depen-
dent, as our results suggest, the defective activation of
PI 3-kinase in hypothalamic neurons could attenuate
the ability of insulin to reduce food intake in the obese
Zucker rats.
In previous studies in rat tissues, IRS-1 tyrosine
phosphorylation correlated to a greater extent to insu-
lin receptor phosphorylation levels, than to IRS-1 pro-
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tein expression, suggesting that modest reductions in
IRS-1 protein amount would not be sufficient to affect
insulin signal transduction [57]. In light of these pre-
vious data we can suggest that the increase in serine
phosphorylation level of IR and IRS-1 could be the
main determinant of reductions in tyrosine phosphory-
lation of these proteins.
The profound insulin resistance on the PI3-kinase
pathway contrasts with the ability of insulin to stimu-
late the MAP kinase pathway in the hypothalamus of
the obese rats. Insulin resistance does not affect the
MAP kinase pathway, since insulin administration in-
creased ERK1/2 phosphorylation to the same extent in
both lean and obese rats. This finding of selective in-
sulin resistance has been recently observed in the vas-
culature of Zucker rats [40]. Two possible reasons for
this difference can be proposed: alternate insulin sig-
nalling pathways and differential signal amplification.
With regard to the former, the MAP kinase pathway
can be activated through Grb2/Sos interaction with
IRS-1/2 or Shc. As IRS-1 tyrosine phosphorylation is
dramatically reduced in the obese animals, it is possi-
ble that insulin activation of the MAP kinase pathway
in vivo primarily occurs through Shc activation. Evi-
dence from in vitro and in vivo studies support this
concept [58, 59]. Maintenance of normal insulin stim-
ulation of the MAP kinase pathway in the presence of
insulin resistance on the PI3-kinase pathway might be
important in the development of insulin resistance.
ERKs can phosphorylate IRS-1 on serine residues
[60], and serine phosphorylation of IRS-1 and of the
insulin receptor itself, as described above, can be im-
plicated in desensitizing insulin receptor signalling
[61].
In summary, our data provide evidence that insulin
can activate both the PI3-kinase-Akt and MAP kinase
pathways in the hypothalamus and that the ability of
insulin to reduce food intake is PI3-kinase-dependent.
In obese Zucker rats, PI3-kinase pathway seems to be
selectively blunted in hypothalamic tissues, compared
with MAP kinase. These findings support the hypoth-
esis that insulin could have anti-obesity actions medi-
ated by the PI3-kinase pathway and that the impaired
PI3-kinase signalling pathway in the hypothalamus
might lead to the development of obesity and insulin
resistance in the obese Zucker rats.
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